Samma S, Tabata S, Nakatsuji F, Yoshie T, Moriya A, Matsuki H, Watanabe S, Babaya K, Hirao Y, Okajima E
Gan To Kagaku Ryoho. 1985 Aug;12(8):1661-8.
The effect of combined tegafur and uracil (UFT) on the development of rat urinary bladder tumors induced by N-butyl-N-(4-hydroxybutyl)nitrosamine (BBN) was studied. Two hundred F344 male rats were divided into 10 groups. Groups 1 to 5 were given 0.05% BBN in drinking water for the initial 8 weeks of the experiment, and Groups 6 to 10 were the controls of the prior 5 groups treated with BBN. UFT in commercial diet was administered at daily doses of 100mg (30.9 mg as FT-207) per kg of body weight in Groups 2 and 4 and 200 mg (61.7 mg as FT-207) per kg of body weight in Groups 3 and 5. Groups 2 and 3 received UFT throughout the period of the experiment, and Groups 4 and 5 for 12 weeks after 8 week treatment with BBN. All animals were sacrificed at 20 weeks, and studied histopathologically. In Groups 1 to 5, urinary bladder tumors developed in 20 of 20, 13 of 20, 6 of 20, 14 of 20 and 6 of 20, respectively. Incidences of tumors in the 4 groups treated with UFT were significantly lower than that in Group 1 treated with BBN alone. This result shows that UFT inhibits the development of urinary bladder tumors in rats induced by BBN.
研究了替加氟与尿嘧啶联合制剂(UFT)对N-丁基-N-(4-羟丁基)亚硝胺(BBN)诱导的大鼠膀胱肿瘤发生的影响。将200只F344雄性大鼠分为10组。第1至5组在实验的最初8周饮用含0.05%BBN的水,第6至10组为前5组用BBN处理后的对照组。第2和4组在商业饲料中给予UFT,剂量为每千克体重每日100mg(相当于FT-207 30.9mg),第3和5组为每千克体重每日200mg(相当于FT-207 61.7mg)。第2和3组在整个实验期间给予UFT,第4和5组在BBN处理8周后给予12周UFT。所有动物在20周时处死并进行组织病理学研究。在第1至5组中,膀胱肿瘤的发生数分别为20只中的20只、20只中的13只、20只中的6只、20只中的14只和20只中的6只。4组接受UFT治疗的肿瘤发生率显著低于单独接受BBN治疗的第1组。该结果表明UFT可抑制BBN诱导的大鼠膀胱肿瘤的发生。